Griseofulvin
Who holds supplier records for Griseofulvin? 1 organisation holds a current record for Griseofulvin: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 1 of them holds a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Griseofulvin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/griseofulvin
Reading the evidence
- One current record
One organisation holds a current DMF or CEP. A record shows a regulatory filing, not current commercial availability or a qualified source for your product.
- No company-level GMP certificate matched
No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.
Current records (1)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Griseofulvin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Chifeng Pharmaceutical Co. LtdChinaCEPActive DMF 18051 · latest filing Feb 2005
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (1)
Certificates of Suitability on the EDQM register for Griseofulvin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 2 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| CHIFENG PHARMACEUTICAL CO., LTD. Chifeng | CN | R1-CEP 2002-143 - Rev 02 Griseofulvin | Nov 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (5)
Organisations whose Type II DMFs for Griseofulvin are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- SHANGHAI PHARMACEUTICAL GROUP CO LTDInactive DMF 16846 · filed Sept 2003
- SHANGHAI ZHONGHUA PHARMACEUTICAL FACTORYInactive DMF 15899 · filed Mar 2002
- Japan · Inactive DMF 13582 · filed Sept 1998
- GLAXOSMITHKLINE LLCInactive DMF 13338 · filed Sept 1998
- WYETH-AYERST LABORATORIESInactive DMF 13342, 13343 · filed Sept 1998
Overview
Griseofulvin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL562).
Chemical identity
- IUPAC name
- (2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methylspiro[1-benzofuran-2,4'-cyclohex-2-ene]-1',3-dione
- Canonical SMILES
- C[C@@H]1CC(=O)C=C([C@]12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC
- InChIKey
- DDUHZTYCFQRHIY-RBHXEPJQSA-N
- Synonyms
- Fulcin, Fulcin 125, Fulcin 500, Fulsovin, Fulvicin p/g, Fulvicin p/g 165, Fulvicin p/g 330, Fulvicin-u/f, Grifulvin v, Grisactin, Grisactin ultra, Grisactin v
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Tubulin Inhibiting Agent
- Physiologic effect
- Decreased Mitosis; Microtubule Inhibition
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Griseofulvin?
1 organisation holds an active US FDA Type II Drug Master File or a CEP for Griseofulvin: Chifeng Pharmaceutical Co. Ltd (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Griseofulvin Drug Master Files are active?
Chifeng Pharmaceutical Co. Ltd (DMF 18051). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Griseofulvin records mean?
5 organisations have only inactive Type II DMFs for Griseofulvin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Griseofulvin have a European Certificate of Suitability?
Yes. 1 organisation holds a valid CEP for Griseofulvin on the EDQM register, including CHIFENG PHARMACEUTICAL CO., LTD. Chifeng (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Griseofulvin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Griseofulvin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.